Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568514

Apexbio Technology LLC Anti-F3-TF-CD142-Ab-Tisotumab
SDP

Catalog No. 5000568514
Encompass

Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab) (CAS No 1418628-81-5) is utilized in the biomedical research field to study hemostasis and thrombosis mechanisms Originating from engineered antibodies it primarily targets tissue factor (TF) a key initiator in the coagulation cascade By binding to TF Tisotumab effectively interrupts the interaction with factor VIIa inhibiting downstream signaling pathways involved in blood coagulation and angiogenesis In vitro activity is often observed in the nanomolar to low micromolar range indicating its potent efficacy It is widely applied in various research models including cell-based assays and animal studies to explore tumor progression and metastatic processes as well as to evaluate potential therapeutic interventions in drug screening programs Experimental concentrations typically depend on the specific research design ensuring adaptability across diverse experimental setups

Catalog No. 50-005-68514 Supplier Apexbio Technology LLC Supplier No. F15935
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab) (CAS No 1418628-81-5) is utilized in the biomedical research field to study hemostasis and thrombosis mechanisms Originating from engineered antibodies it primarily targets tissue factor (TF) a key initiator in the coagulation cascade By binding to TF Tisotumab effectively interrupts the interaction with factor VIIa inhibiting downstream signaling pathways involved in blood coagulation and angiogenesis In vitro activity is often observed in the nanomolar to low micromolar range indicating its potent efficacy It is widely applied in various research models including cell-based assays and animal studies to explore tumor progression and metastatic processes as well as to evaluate potential therapeutic interventions in drug screening programs Experimental concentrations typically depend on the specific research design ensuring adaptability across diverse experimental setups

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.